Immunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor β antibody

Infection and Immunity

Volumn 71, Issue 5, 2003, Pages 2439-2446

  Mookerjee, Ananda ^a   Sen, Parimal C ^a   Ghose, Asoke C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; DIACYLGLYCEROL; IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P42/44; NEUTRALIZING ANTIBODY; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLSERINE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL CULTURE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; HAMSTER; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOBLOTTING; LEISHMANIA DONOVANI; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MACROPHAGE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

ANIMALS; CRICETINAE; IMMUNE TOLERANCE; IMMUNOBLOTTING; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; OKADAIC ACID; PHOSPHORYLATION; PROTEIN KINASE C; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0242500351     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.5.2439-2446.2003     Document Type: Article

References (59)

1. Altman, A., K. M. Coggeshall, and T. Mustelin. 1990. Molecular events mediating T cell activation. Adv. Immunol. 48:227-360.
2. Bogdan, C., and M. Rollinghof. 1998. The immune response to Leishmania: mechanism of parasite control and evasion. Int. J. Parasitol. 28:121-134.
3. Bogdan, C., and M. Rollinghof. 1999. How do protozoan parasites survive inside macrophages? Parasitol. Today 15:22-28.
4. Bollag, D. M., M. D. Rozycki, and S. J. Edelstein. 1996. Protein methods, 2nd ed. Wiley-Liss, New York, N.Y.
5. Bright, J. J., and S. Sriram. 1998. TGF-β inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol. 161:1772-1777.
6. Bryceson, A. D. M. 1996. Leishmaniasis, p. 1213-1245. In G. C. Cook (ed.), Manson's tropical diseases. W. B. Saunders, London, United Kingdom.
7. Buchmuller-Rouiller, Y., and J. Mauel. 1987. Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp. Infect. Immun. 55:587-590.
8. Campbell, J. D., G. Cook, S. E. Robertson, A. Fraser, K. S. Boyd, J. A. Gracie, and I. M. Franklin. 2001. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT 3 and STAT 5 by tumor-derived TGF-β is reversed by IL-15. J. Immunol. 167:553-561.
9. Carvalho, E. M., R. Badaro, S. G. Reed, T. C. Jones, and W. D. Johnson. 1985. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Investig. 76:2066-2069.
10. Carvalho, E. M., R. S. Teixeira, and W. D. Johnson, Jr. 1981. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect. Immun. 33:498-502.
11. Choudhry, M. A., O. Sir, and M. M. Sayeed. 2001. TGF-β abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells. Shock 15:193-199.
12. Cillari, E., G. Vitale, F. Arcoleo, P. D'Agostino, C. Mocciaro, G. Gambino, K. Malta, G. Stassi, C. Giordano, S. Milano, and S. Mansueto. 1995. In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis. Cytokine 7:740-745.
13. Cohen, P. T. 1997. Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem. Sci. 22:245-247.
14. Dasgupta, S. 1997. Ph.D. thesis. Calcutta University, Kolkata, India.
15. Dasgupta, S., A. Mookerjee, S. K. Chowdhury, and A. C. Ghose. 1999. Immunosuppression in hamsters with progressive visceral leishmaniasis: an evaluation of the role of nitric oxide toward impairment of the lymphoproliferative response. Parasitol. Res. 85:594-596.
16. Dempsey, E. C., A. C. Newton, D. Mochly-Rosen, A. P. Fields, M. E. Reyland, P. A. Insel, and R. O. Messing. 2000. Protein kinase C isozymes and the regulation of diverse cell responses (EB 2000 symposium report). Am. J. Physiol. Lung Cell Mol. Physiol. 279:L429-L438.
17. Descoteaux, A., G. Matlashewski, and S. J. Turco. 1992. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J. Immunol. 149:3008-3015.
18. Forget, G., K. A. Siminovitch, S. Brochu, S. Rivest, D. Radzioch, and M. Olivier. 2001. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur. J. Immunol. 31:3185-3196.
19. Ghose, A. C., A. Mookerjee, K. Sengupta, A. K. Ghosh, S. Dasgupta, and P. K. Roy. 1999. Therapeutic and prophylactic uses of protein A in the control of Leishmania donovani infection in experimental animals. Immunol. Lett. 65:175-181.
20. Ghose, A. C., J. P. Halder, S. C. Pal, B. P. Mishra, and K. K. Mishra. 1980. Serological investigation on Indian kala-azar. Clin. Exp. Immunol. 40:318-326.
21. Giehl, K., B. Seidel, P. Gierschik, G. Adler, and A. Menke. 2000. TGF β1 represses proliferation of pancreatic carcinoma cells which correlates with Smad 4-independent inhibition of ERK activation. Oncogene 19:4531-4541.
22. Gifawesen, C., and J. P. Farrell. 1989. Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters. Infect. Immun. 57:3091-3096.
23. Giorgione, J. R., S. J. Turco, and R. M. Epand. 1996. Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishamania donavani. Proc. Natl. Acad. Sci. USA 93:11634-11639.
24. Gomes, N. A., C. R. Gattass, V. Barreto-de-Souza, M. E. Wilson, and G. A. DosReis. 2000. TGF-β mediates CTLA-4 suppression of cellular immunity in murine kala azar. J. Immunol. 164:2001-2008.
25. Good, J. A., W. H. Ziegler, D. B. Parekh, D. R. Alessi, P. Cohen, and P. J. Parker. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK 1. Science 281:2042-2045.
26. Halder, J. P., S. Ghose, K. C. Saha, and A. C. Ghose. 1983. Cell-mediated immune response in Indian kala-azar and post-kala azar dermal leishmaniasis. Infect. Immun. 42:702-707.
27. Ho, M., D. K. Koech, D. H. Iha, and A. D. M. Bryceson. 1983. Immunosuppression in Kenyan visceral leishmaniasis. Clin. Exp. Immunol. 51:207-214.
28. Kaibuchi, K., Y. Takai, and Y. Nishizuka. 1985. Protein kinase C and calcium ion in mitogenic response of macrophage-depleted human peripheral lymphocytes. J. Biol. Chem. 260:1366-1369.
29. Kaye, P. M. 1995. Costimulation and the regulation of antimicrobial immunity. Immunol. Today 16:423-427.
30. + T cells in intracellular infections in humans: leishmaniasis as an example. Immunol. Today 17:13-16.
31. Kikkawa, U., Y. Takai, Y. Tanaka, R. Miyake, and Y. Nishizuka. 1983. Protein kinase C as a possible receptor protein of tumor promoting phorbol esters. J. Biol. Chem. 258:11442-11445.
32. 2+, phospholipid dependent protein kinase associated with plasma membrane. Nature 301:621-623.
33. Matte, C., J. F. Marquis, J. Blanchette, P. Gros, R. Faure, B. I. Posner, and M. Olivier. 2000. Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide. Eur. J. Immunol. 30:2555-2564.
34. McNeely, T. B., G. Rosen, M. V. Londner, and S. J. Turco. 1989. Inhibitory effects of protein kinase C activity by lipophosphoglycan fragments and glycophosphatidylinositol antigens of protozoan parasite Leishmania. Biochem. J. 259:601-604.
35. Melby, P. C., B. Chandrasekar, W. Zhao, and J. E. Coe. 2001. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J. Immunol. 166:1912-1920.
36. Melby, P. C., V. V. Tryon, B. Chandrasekar, and G. L. Freeman. 1998. Cloning of Syrian hamster (Mesocricetus auratus) cytokine DNAs and analysis of cytokine in RNA expression in experimental visceral leishmaniasis. Infect. Immun. 66:2135-2142.
37. Moore, K. J., S. Labreque, and G. Matlashewski. 1993. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction. J. Immunol. 150:4457-4465.
38. Murphy, M., C. R. Engwerda, P. M. A. Gorak, and P. M. Kaye. 1997. B7-2 blockade enhances T cell responses to Leishmania donovani. J. Immunol. 159:4460-4466.
39. Nandan, D., R. Lo, and N. E. Reiner. 1999. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-Fos and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect. Immun. 67:4055-4063.
40. Ng, T., A. Squire, G. Hansra, F. Bornancin, C. Prevostel, A. Hanby, W. Harris, D. Barnes, S. Schmidt, H. Mellor, P. I. H. Bastiaens, and P. J. Parker. 1999. Imaging protein kinase C α activation in cells. Science 283: 2085-2089.
41. Nickol, A. D., and P. F. Bonventre. 1985. Immunosuppression associated with visceral leishmaniasis of hamsters. Parasite Immunol. 7:439-449.
42. Nickol, A. D., and P. F. Bonventre. 1985. Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells. Infect. Immun. 50:160-168.
43. Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:484-496.
44. Olivier, M., B. Romero-Gallo, C. Matte, J. Blanchette, B. I. Posner, M. J. Tremblay, and R. Faure. 1998. Modulation of interferon-γ-induced macrophage activation by phosphotyrosine phosphatases inhibition. J. Biol. Chem. 273:13944-13949.
45. Olivier, M., R. W. Brownsey, and N. E. Reiner. 1992. Defective stimulus response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc. Natl. Acad. Sci. USA 89:7481-7485.
46. Pingel, S., Z. Wang, and R. M. Locksley. 1998. Distribution of protein kinase C isoforms after infection of macrophages with Leishmania major. Infect. Immun. 66:1795-1799.
47. Puente, L. G., J. C. Stone, and H. L. Ostergaard. 2000. Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding proteins. J. Immunol. 165:6865-6871.
48. Reiner, N. E. 1994. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 15:374-380.
49. Rodrigues, V., Jr., J. S. D. Silva, and A. Campos-Neto. 1998. Transforming growth factor β and immunosuppression in experimental visceral leishmaniasis. Infect. Immun. 66:1233-1236.
50. Sacks, D. L., and J. A. Louis. 1993. Leishmaniasis, p. 237-268. In K. S. Warren (ed.), Immunology and molecular biology of parasitic infections. Blackwell, New York, N.Y.
51. Sacks, D. L., S. L. Lal, S. N. Srivastava, J. Blackwell, and F. A. Neva. 1987. An analysis of T cell responsiveness in Indian kala-azar. J. Immunol. 138: 908-913.
52. Seger, R., N. G. Ahn, J. Posada, E. S. Munar, A. M. Jensen, J. A. Cooper, M. H. Cobb, and E. G. Krebs. 1992. Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor stimulated A431 cells. J. Biol. Chem. 267:14373-14381.
53. Solbach, W., and T. Laskay. 2000. The host response to Leishmania infection. Adv. Immunol. 74:275-317.
54. Stauber, L. A., G. M. Franchino, and J. Grun. 1958. An eight day method for screening compounds against Leishmania donovani in the golden hamster. J. Protozool. 5:269-273.
55. + T cells. J. Immunol. 157:1508-1513.
56. Toker, A., and A. C. Newton. 2000. Cellular signaling: pivoting around PDK 1. Cell 103:185-188.
57. Truneh, A., F. Albert, P. Golstein, and A. M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313:318-320.
58. Wilson, M. E., B. M. Young, B. L. Davidson, K. A. Mente, and S. E. McGowan. 1998. The importance of TGF-β in murine visceral leishmaniasis. J. Immunol. 161:6148-6155.
59. Yoshizumi, M., H. Wang, C. M. Hsieh, N. E. Sibinga, M. A. Perrella, and M. E. Lee. 1997. Down-regulation of the cyclin A promoter by transforming growth factor-β1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein. J. Biol. Chem. 272:22259-22264.